ADAMTS2
A disintegrin and metalloproteinase with thrombospondin motifs 2
Also known as: ADAM-TS2, ADAMTS-3, ATS2_HUMAN, hPCPNI, NPI, PCINP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95450
- Gene
- ADAMTS2
- Ensembl
- ENSG00000087116
- Chromosome
- 5
- Canonical length
- 1211 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins
- Subcellular location
- Vesicles,Plasma membrane
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature procollagen N-proteinase. This proteinase excises the N-propeptide of the fibrillar procollagens types I-III and type V. Mutations in this gene cause Ehlers-Danlos syndrome type VIIC, a recessively inherited connective-tissue disorder. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
1211 residues, UniProt reviewed canonical sequence.
>O95450|ADAMTS2
1 MDPPAGAARR LLCPALLLLL LLLPPPLLPP PPPPANARLA AAADPPGGPL GHGAERILAV
61 PVRTDAQGRL VSHVVSAATS RAGVRARRAA PVRTPSFPGG NEEEPGSHLF YNVTVFGRDL
121 HLRLRPNARL VAPGATMEWQ GEKGTTRVEP LLGSCLYVGD VAGLAEASSV ALSNCDGLAG
181 LIRMEEEEFF IEPLEKGLAA QEAEQGRVHV VYRRPPTSPP LGGPQALDTG ASLDSLDSLS
241 RALGVLEEHA NSSRRRARRH AADDDYNIEV LLGVDDSVVQ FHGKEHVQKY LLTLMNIVNE
301 IYHDESLGAH INVVLVRIIL LSYGKSMSLI EIGNPSQSLE NVCRWAYLQQ KPDTGHDEYH
361 DHAIFLTRQD FGPSGMQGYA PVTGMCHPVR SCTLNHEDGF SSAFVVAHET GHVLGMEHDG
421 QGNRCGDEVR LGSIMAPLVQ AAFHRFHWSR CSQQELSRYL HSYDCLLDDP FAHDWPALPQ
481 LPGLHYSMNE QCRFDFGLGY MMCTAFRTFD PCKQLWCSHP DNPYFCKTKK GPPLDGTMCA
541 PGKHCFKGHC IWLTPDILKR DGSWGAWSPF GSCSRTCGTG VKFRTRQCDN PHPANGGRTC
601 SGLAYDFQLC SRQDCPDSLA DFREEQCRQW DLYFEHGDAQ HHWLPHEHRD AKERCHLYCE
661 SRETGEVVSM KRMVHDGTRC SYKDAFSLCV RGDCRKVGCD GVIGSSKQED KCGVCGGDNS
721 HCKVVKGTFT RSPKKHGYIK MFEIPAGARH LLIQEVDATS HHLAVKNLET GKFILNEEND
781 VDASSKTFIA MGVEWEYRDE DGRETLQTMG PLHGTITVLV IPVGDTRVSL TYKYMIHEDS
841 LNVDDNNVLE EDSVVYEWAL KKWSPCSKPC GGGSQFTKYG CRRRLDHKMV HRGFCAALSK
901 PKAIRRACNP QECSQPVWVT GEWEPCSQTC GRTGMQVRSV RCIQPLHDNT TRSVHAKHCN
961 DARPESRRAC SRELCPGRWR AGPWSQCSVT CGNGTQERPV LCRTADDSFG ICQEERPETA
1021 RTCRLGPCPR NISDPSKKSY VVQWLSRPDP DSPIRKISSK GHCQGDKSIF CRMEVLSRYC
1081 SIPGYNKLCC KSCNLYNNLT NVEGRIEPPP GKHNDIDVFM PTLPVPTVAM EVRPSPSTPL
1141 EVPLNASSTN ATEDHPETNA VDEPYKIHGL EDEVQPPNLI PRRPSPYEKT RNQRIQELID
1201 EMRKKEMLGK FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADAMTS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 30 nTPM
- spleen: 29 nTPM
- lung: 24 nTPM
- blood vessel: 22 nTPM
- breast: 19 nTPM
- heart muscle: 19 nTPM
Single-cell type
- hepatic stellate cells: 607 nCPM
- kupffer cells: 237 nCPM
- monocytes: 213 nCPM
- monocyte progenitors: 205 nCPM
- thyrotrophs: 184 nCPM
- fibro-adipogenic progenitors: 116 nCPM
Immune cell
- basophil: 0.3 nTPM
- neutrophil: 0.3 nTPM
- myeloid DC: 0.2 nTPM
- naive B-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
Brain region
- pons: 10 nTPM
- cerebral cortex: 9 nTPM
- midbrain: 8.5 nTPM
- medulla oblongata: 7.5 nTPM
- thalamus: 6.6 nTPM
- white matter: 5.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADAMTS2.
Disease | AllUniProt
Conditions ADAMTS2 is implicated in, by any mechanism.
- Ehlers-Danlos syndrome, dermatosparaxis type (EDSDERMS) MIM:225410
Disease | GeneticClinVar
127 pathogenic / likely-pathogenic of 2,066 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ehlers-Danlos syndrome, dermatosparaxis type
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 1.43
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- collagen catabolic process
- collagen fibril organization
- extracellular matrix organization
- lung development
- protein processing
- proteolysis
- skin development
- spermatogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thrombospondin type-1 (TSP1) repeat
- Peptidase M12B, ADAM/reprolysin
- Peptidase M12B, propeptide
- ADAMTS/ADAMTS-like, Spacer 1
- PLAC
- ADAMTS/ADAMTS-like
- Metallopeptidase, catalytic domain superfamily
- Thrombospondin type-1 repeat superfamily
- ADAMTS, cysteine-rich domain 2
- ADAMTS/ADAMTS-like, cysteine-rich domain 3
- ADAMTS and ADAMTS-like
- Thrombospondin type 1 domain
- Reprolysin (M12B) family zinc metalloprotease
- Reprolysin family propeptide
- ADAM-TS Spacer 1
- ADAMTS cysteine-rich domain 2
- Thrombospondin type 1 domain
- ADAMTS cysteine-rich domain
- Peptidase M12B, ADAM-TS2
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADAMTS2 as an antibody target. Whether an autoantibody or antibody against ADAMTS2 could matter depends on whether native ADAMTS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADAMTS2 is annotated as secreted, so native ADAMTS2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ADAMTS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...